研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2016 年 · SiM
Statistics in Medicine,2016 年发表的 307 篇,新的在前。点标题看作者和摘要。回到 2016 年
- Point estimation and p‐values in phase II adaptive two‐stage designs with a binary endpoint · SiM · 2016-12-27 · 在第 1 页
- Imbalance properties of centre‐stratified permuted‐block and complete randomisation for several treatments in a clinical trial · SiM · 2016-12-27 · 在第 1 页
- Flexible parametric modelling of the cause‐specific cumulative incidence function · SiM · 2016-12-22 · 在第 1 页
- An Expectation Maximization algorithm for fitting the generalized odds‐rate model to interval censored data · SiM · 2016-12-21 · 在第 1 页
- Assessing treatment efficacy in the presence of diagnostic errors · SiM · 2016-12-20 · 在第 1 页
- A Bayesian approach to sequential meta‐analysis · SiM · 2016-12-20 · 在第 1 页
- Statistical assessment of treatment response in a cancer patient based on pre‐therapy and post‐therapy FDG‐PET scans · SiM · 2016-12-18 · 在第 1 页
- Semiparametric time varying coefficient model for matched case‐crossover studies · SiM · 2016-12-15 · 在第 1 页
- Statistical inferences for data from studies conducted with an aggregated multivariate outcome‐dependent sample design · SiM · 2016-12-14 · 在第 1 页
- Assessing a surrogate predictive value: a causal inference approach · SiM · 2016-12-13 · 在第 1 页
- Comparison of approaches for incorporating new information into existing risk prediction models · SiM · 2016-12-11 · 在第 1 页
- Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion? · SiM · 2016-12-07 · 在第 2 页
- Longitudinal beta‐binomial modeling using GEE for overdispersed binomial data · SiM · 2016-12-05 · 在第 2 页
- Imputing estrogen receptor (ER) status in a population‐based cancer registry: a sensitivity analysis · SiM · 2016-12-05 · 在第 2 页
- Quantifying indirect evidence in network meta‐analysis · SiM · 2016-12-04 · 在第 2 页
- Estimating personalized diagnostic rules depending on individualized characteristics · SiM · 2016-12-04 · 在第 2 页
- One-stage individual participant data meta-analysis models: estimation of treatment-covariate interactions must avoid ecological bias by separating out within-trial and across-trial information · SiM · 2016-12-01 · 在第 2 页
- Handbook of Big Data · SiM · 2016-12-01 · 在第 2 页
- A composite likelihood approach in testing for Hardy Weinberg Equilibrium using family‐based genetic survey data · SiM · 2016-11-30 · 在第 2 页
- Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials · SiM · 2016-11-28 · 在第 2 页
- Estimation of state occupancy probabilities in multistate models with dependent intermittent observation, with application to HIV viral rebounds · SiM · 2016-11-28 · 在第 3 页
- A closed testing procedure to select an appropriate method for updating prediction models · SiM · 2016-11-28 · 在第 3 页
- Estimating time‐dependent ROC curves using data under prevalent sampling · SiM · 2016-11-27 · 在第 3 页
- Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment · SiM · 2016-11-27 · 在第 3 页
- The median hazard ratio: a useful measure of variance and general contextual effects in multilevel survival analysis · SiM · 2016-11-25 · 在第 3 页
- A note on statistical repeatability and study design for high-throughput assays · SiM · 2016-11-24 · 在第 3 页
- Cluster detection of spatial regression coefficients · SiM · 2016-11-22 · 在第 3 页
- A U -statistics based approach to sample size planning of two-arm trials with discrete outcome criterion aiming to establish either superiority or noninferiority · SiM · 2016-11-22 · 在第 3 页
- Simulating survival data with predefined censoring rates for proportional hazards models · SiM · 2016-11-21 · 在第 3 页
- Inconsistency and drop‐minimum data analysis · SiM · 2016-11-21 · 在第 3 页
- A time‐varying effect model for examining group differences in trajectories of zero‐inflated count outcomes with applications in substance abuse research · SiM · 2016-11-21 · 在第 3 页
- Meta-analysis of aggregate data on medical events · SiM · 2016-11-18 · 在第 3 页
- Analysis of proportional mean residual life model with latent variables · SiM · 2016-11-18 · 在第 3 页
- Estimation of conditional and marginal odds ratios using the prognostic score · SiM · 2016-11-17 · 在第 3 页
- A studentized permutation test for three‐arm trials in the ‘gold standard’ design · SiM · 2016-11-16 · 在第 3 页
- Multiple imputation in the presence of non-normal data · SiM · 2016-11-15 · 在第 3 页
- Inference and sample size calculation for clinical trials with incomplete observations of paired binary outcomes · SiM · 2016-11-10 · 在第 3 页
- Asymmetric inner wedge group sequential tests with applications to verifying whether effective drug concentrations are similar in adults and children · SiM · 2016-11-08 · 在第 3 页
- Analyzing semi-competing risks data with missing cause of informative terminal event · SiM · 2016-11-03 · 在第 3 页
- Targeted use of growth mixture modeling: a learning perspective · SiM · 2016-11-02 · 在第 4 页
- Monotonic single-index models to assess drug interactions · SiM · 2016-11-02 · 在第 4 页
- Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments · SiM · 2016-11-02 · 在第 4 页
- Designing therapeutic cancer vaccine trials with delayed treatment effect · SiM · 2016-11-02 · 在第 4 页
- Goodness‐of‐fit test for monotone proportional subdistribution hazards assumptions based on weighted residuals · SiM · 2016-10-28 · 在第 4 页
- Bayesian estimation in random effects meta‐analysis using a non‐informative prior · SiM · 2016-10-28 · 在第 4 页
- On the estimation of intracluster correlation for time-to-event outcomes in cluster randomized trials · SiM · 2016-10-27 · 在第 4 页
- Weighted analysis of composite endpoints with simultaneous inference for flexible weight constraints · SiM · 2016-10-26 · 在第 4 页
- Change-point detection of cognitive states across multiple trials in functional neuroimaging · SiM · 2016-10-26 · 在第 4 页
- A case‐cohort approach for multi‐state models in hospital epidemiology · SiM · 2016-10-24 · 在第 4 页
- A frailty model for recurrent events during alternating restraint and non-restraint time periods · SiM · 2016-10-18 · 在第 5 页
- A joint modelling approach for multistate processes subject to resolution and under intermittent observations · SiM · 2016-10-17 · 在第 5 页
- Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ · SiM · 2016-10-16 · 在第 5 页
- A new concordance measure for risk prediction models in external validation settings · SiM · 2016-10-15 · 在第 5 页
- Models for zero‐inflated, correlated count data with extra heterogeneity: when is it too complex? · SiM · 2016-10-13 · 在第 5 页
- Comparisons of risk prediction methods using nested case‐control data · SiM · 2016-10-13 · 在第 5 页
- Understanding the effects of conditional dependence in research studies involving imperfect diagnostic tests · SiM · 2016-10-11 · 在第 5 页
- Modelling hospital length of stay using convolutive mixtures distributions · SiM · 2016-10-05 · 在第 5 页
- Discrimination slope and integrated discrimination improvement – properties, relationships and impact of calibration · SiM · 2016-10-03 · 在第 5 页
- Choosing appropriate analysis methods for cluster randomised cross‐over trials with a binary outcome · SiM · 2016-09-28 · 在第 7 页
- Skellam process with resetting: a neural spike train model · SiM · 2016-09-26 · 在第 7 页
- Segmented polynomials for incidence rate estimation from prevalence data · SiM · 2016-09-26 · 在第 7 页
- Promoting similarity of model sparsity structures in integrative analysis of cancer genetic data · SiM · 2016-09-25 · 在第 7 页
- Monitoring potential adverse event rate differences using data from blinded trials: the canary in the coal mine · SiM · 2016-09-25 · 在第 7 页
- Comparing a stratified treatment strategy with the standard treatment in randomized clinical trials · SiM · 2016-09-25 · 在第 7 页
- Major Greenwood (1880–1949): the biography · SiM · 2016-09-22 · 在第 7 页
- Optimal sequential enrichment designs for phase II clinical trials · SiM · 2016-09-19 · 在第 7 页
- Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials · SiM · 2016-09-19 · 在第 8 页
- A Bayesian dose‐finding design incorporating toxicity data from multiple treatment cycles · SiM · 2016-09-15 · 在第 8 页
- Designs for phase I trials in ordered groups · SiM · 2016-09-14 · 在第 8 页
- Control charts for monitoring accumulating adverse event count frequencies from single and multiple blinded trials · SiM · 2016-09-13 · 在第 8 页
- A special case of reduced rank models for identification and modelling of time varying effects in survival analysis · SiM · 2016-09-13 · 在第 8 页
- A novel chi‐square statistic for detecting group differences between pathways in systems epidemiology · SiM · 2016-09-07 · 在第 8 页
- Robust empirical calibration of p‐values using observational data · SiM · 2016-09-04 · 在第 8 页
- P‐values and decision‐making: discussion of ‘Limitations of empirical calibration of p‐values using observational data’ · SiM · 2016-09-04 · 在第 8 页
- Bayesian quantile regression-based nonlinear mixed-effects joint models for time-to-event and longitudinal data with multiple features · SiM · 2016-09-04 · 在第 8 页
- Objective Bayesian model selection for Cox regression · SiM · 2016-08-31 · 在第 8 页
- Estimation for zero-inflated over-dispersed count data model with missing response · SiM · 2016-08-31 · 在第 8 页
- A simple and robust method for multivariate meta‐analysis of diagnostic test accuracy · SiM · 2016-08-31 · 在第 8 页
- A practical Bayesian design to identify the maximum tolerated dose contour for drug combination trials · SiM · 2016-08-31 · 在第 9 页
- A marginal structural model for recurrent events in the presence of time‐dependent confounding: non‐specific effects of vaccines on child hospitalisations · SiM · 2016-08-31 · 在第 9 页
- Implementing informative priors for heterogeneity in meta‐analysis using meta‐regression and pseudo data · SiM · 2016-08-30 · 在第 9 页
- Accounting for measurement error in biomarker data and misclassification of subtypes in the analysis of tumor data · SiM · 2016-08-24 · 在第 9 页
- Multi‐arm group sequential designs with a simultaneous stopping rule · SiM · 2016-08-23 · 在第 9 页
- Methods for assessing the reliability of quality of life based on SF-36 · SiM · 2016-08-23 · 在第 9 页
- Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis · SiM · 2016-08-22 · 在第 9 页
- A Bayesian adaptive phase I–II trial design for optimizing the schedule of therapeutic cancer vaccines · SiM · 2016-08-21 · 在第 9 页
- Pseudo maximum likelihood approach for the analysis of multivariate left‐censored longitudinal data · SiM · 2016-08-18 · 在第 9 页
- A scalable approach to measuring the impact of nonignorable nonresponse with an EMA application · SiM · 2016-08-18 · 在第 10 页
- A robust two‐stage design identifying the optimal biological dose for phase I/II clinical trials · SiM · 2016-08-18 · 在第 10 页
- Instrumental variable analysis of multiplicative models with potentially invalid instruments · SiM · 2016-08-16 · 在第 10 页
- Improved power in crossover designs through linear combinations of baselines · SiM · 2016-08-16 · 在第 10 页
- Estimating relative risk of a log‐transformed exposure measured in pools · SiM · 2016-08-16 · 在第 10 页
- Analysis of multiple‐variable missing‐not‐at‐random survey data for child lead surveillance using NHANES · SiM · 2016-08-15 · 在第 10 页
- Bayesian joint ordinal and survival modeling for breast cancer risk assessment · SiM · 2016-08-14 · 在第 10 页
- Evaluation of the effects of multiple providers in complex surgical interventions · SiM · 2016-08-10 · 在第 10 页
- Trivariate mover‐stayer counting process models for investigating joint damage in psoriatic arthritis · SiM · 2016-08-08 · 在第 10 页
- The mathematics of random mutation and natural selection for multiple simultaneous selection pressures and the evolution of antimicrobial drug resistance · SiM · 2016-08-08 · 在第 10 页
- Modeling zero‐modified count and semicontinuous data in health services research part 2: case studies · SiM · 2016-08-08 · 在第 11 页
- Modeling zero‐modified count and semicontinuous data in health services research Part 1: background and overview · SiM · 2016-08-08 · 在第 11 页
- Comparison of drug dissolution profiles: a proposal based on tolerance limits · SiM · 2016-08-08 · 在第 11 页
- Bayesian bent‐cable growth mixture tobit models for longitudinal data with skewness and detection limit: application to AIDS studies · SiM · 2016-08-08 · 在第 11 页
- A flexible parametric approach to examining spatial variation in relative survival · SiM · 2016-08-08 · 在第 11 页
- Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials · SiM · 2016-08-03 · 在第 11 页
- Biomarker‐driven population enrichment for adaptive oncology trials with time to event endpoints · SiM · 2016-08-03 · 在第 11 页
- Residual risk and waste in donated blood with pooled nucleic acid testing · SiM · 2016-08-02 · 在第 11 页
- Multiple imputation of completely missing repeated measures data within person from a complex sample: application to accelerometer data in the National Health and Nutrition Examination Survey · SiM · 2016-08-02 · 在第 11 页
- Robust estimation of partially linear models for longitudinal data with dropouts and measurement error · SiM · 2016-07-26 · 在第 11 页
- Prevalence odds ratio versus prevalence ratio: choice comes with consequences · SiM · 2016-07-26 · 在第 12 页
- Integrating independent spatio‐temporal replications to assess population trends in disease spread · SiM · 2016-07-24 · 在第 12 页
- Identifying cost‐effective dynamic policies to control epidemics · SiM · 2016-07-24 · 在第 12 页
- Estimating overall exposure effects for the clustered and censored outcome using random effect Tobit regression models · SiM · 2016-07-24 · 在第 12 页
- Using semi‐Markov processes to study timeliness and tests used in the diagnostic evaluation of suspected breast cancer · SiM · 2016-07-21 · 在第 12 页
- Multiple imputation of missing covariates for the Cox proportional hazards cure model · SiM · 2016-07-21 · 在第 12 页
- Evaluation of subset matching methods and forms of covariate balance · SiM · 2016-07-21 · 在第 12 页
- Bias and variance reduction in nonparametric estimation of time‐dependent accuracy measures · SiM · 2016-07-21 · 在第 12 页
- A weighted U statistic for association analyses considering genetic heterogeneity · SiM · 2016-07-20 · 在第 12 页
- Performance of toxicity probability interval based designs in contrast to the continual reassessment method · SiM · 2016-07-19 · 在第 12 页
- Estimands in clinical trials – broadening the perspective · SiM · 2016-07-19 · 在第 12 页
- Adaptive pre‐specification in randomized trials with and without pair‐matching · SiM · 2016-07-19 · 在第 12 页
- Optimally combining propensity score subclasses · SiM · 2016-07-18 · 在第 12 页
- Net reclassification index at event rate: properties and relationships · SiM · 2016-07-18 · 在第 12 页
- A note on posterior predictive checks to assess model fit for incomplete data · SiM · 2016-07-18 · 在第 12 页
- Multivariate analysis of longitudinal rates of change · SiM · 2016-07-14 · 在第 12 页
- An alternative empirical likelihood method in missing response problems and causal inference · SiM · 2016-07-14 · 在第 12 页
- An adaptive design for updating the threshold value of a continuous biomarker · SiM · 2016-07-14 · 在第 12 页
- Estimating time to event characteristics via longitudinal threshold regression models ‐ an application to cervical dilation progression · SiM · 2016-07-13 · 在第 12 页
- Estimating causal contrasts involving intermediate variables in the presence of selection bias · SiM · 2016-07-13 · 在第 12 页
- Under-reported data analysis with INAR-hidden Markov chains · SiM · 2016-07-11 · 在第 13 页
- Time-dependent summary receiver operating characteristics for meta-analysis of prognostic studies · SiM · 2016-07-11 · 在第 13 页
- Semi-varying coefficient multinomial logistic regression for disease progression risk prediction · SiM · 2016-07-11 · 在第 13 页
- Edgewise and subgraph‐level tests for brain networks · SiM · 2016-07-11 · 在第 14 页
- The rapid enrollment design for Phase I clinical trials · SiM · 2016-07-10 · 在第 15 页
- Bayesian shrinkage approach for a joint model of longitudinal and survival outcomes assuming different association structures · SiM · 2016-07-06 · 在第 15 页
- Analyzing infant head flatness and asymmetry using kernel density estimation of directional surface data from a craniofacial 3D model · SiM · 2016-07-06 · 在第 15 页
- A comparison of the variance estimation methods for heteroscedastic nonlinear models · SiM · 2016-07-06 · 在第 15 页
- A Bayesian multivariate joint frailty model for disease recurrences and survival · SiM · 2016-07-06 · 在第 15 页
- Longitudinal latent variable models given incompletely observed biomarkers and covariates · SiM · 2016-07-04 · 在第 15 页
- Too many covariates and too few cases? – a comparative study · SiM · 2016-06-30 · 在第 16 页
- Evaluation of predictive capacities of biomarkers based on research synthesis · SiM · 2016-06-30 · 在第 16 页
- An objective Bayesian analysis of a crossover design via model selection and model averaging · SiM · 2016-06-30 · 在第 16 页
- Sample size calculation for stepped wedge and other longitudinal cluster randomised trials · SiM · 2016-06-28 · 在第 16 页
- Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study · SiM · 2016-06-27 · 在第 16 页
- Testing conditional independence in sets ofI×Jtables by means of moment and correlation score tests with application to HPV vaccine · SiM · 2016-06-27 · 在第 16 页
- Identification of subgroups with differential treatment effects for longitudinal and multiresponse variables · SiM · 2016-06-27 · 在第 16 页
- Structured fusion lasso penalized multi‐state models · SiM · 2016-06-23 · 在第 16 页
- Statistical issues related to dietary intake as the response variable in intervention trials · SiM · 2016-06-20 · 在第 16 页
- Measuring the individual benefit of a medical or behavioral treatment using generalized linear mixed‐effects models · SiM · 2016-06-20 · 在第 16 页
- Measuring concurrency using a joint multistate and point process model for retrospective sexual history data · SiM · 2016-06-20 · 在第 16 页
- Comparison of two correlated ROC curves at a given specificity or sensitivity level · SiM · 2016-06-20 · 在第 16 页
- Who really gets strep sore throat? Confounding and effect modification of a time‐varying exposure on recurrent events · SiM · 2016-06-16 · 在第 16 页
- The analysis of terminal endpoint events in stepped wedge designs · SiM · 2016-06-16 · 在第 16 页
- Martingale residual‐based method to control for confounders measured only in a validation sample in time‐to‐event analysis · SiM · 2016-06-16 · 在第 16 页
- Individualizing drug dosage with longitudinal data · SiM · 2016-06-16 · 在第 16 页
- Discovering early diabetic neuropathy from epidermal nerve fiber patterns · SiM · 2016-06-16 · 在第 16 页
- A graphical model approach to systematically missing data in meta‐analysis of observational studies · SiM · 2016-06-16 · 在第 16 页
- A goodness‐of‐fit test for the ordered stereotype model · SiM · 2016-06-16 · 在第 16 页
- A flexible cure rate model with dependent censoring and a known cure threshold · SiM · 2016-06-16 · 在第 16 页
- Efficient treatment allocation in 2 × 2 cluster randomized trials, when costs and variances are heterogeneous · SiM · 2016-06-07 · 在第 17 页
- Correcting for binomial measurement error in predictors in regression with application to analysis of DNA methylation rates by bisulfite sequencing · SiM · 2016-06-06 · 在第 17 页
- Comparing results from multiple imputation and dynamic marginal structural models for estimating when to start antiretroviral therapy · SiM · 2016-06-06 · 在第 17 页
- Three measures of explained variation for correlated survival data under the proportional hazards mixed‐effects model · SiM · 2016-05-30 · 在第 17 页
- Robust analysis of secondary phenotypes in case‐control genetic association studies · SiM · 2016-05-30 · 在第 17 页
- Propensity score matching with clustered data. An application to the estimation of the impact of caesarean section on the Apgar score · SiM · 2016-05-30 · 在第 17 页
- A conditional estimating equation approach for recurrent event data with additional longitudinal information · SiM · 2016-05-30 · 在第 17 页
- Time‐varying coefficients models for recurrent event data when different varying coefficients admit different degrees of smoothness: application to heart disease modeling · SiM · 2016-05-29 · 在第 17 页
- Bayesian adjustment for the misclassification in both dependent and independent variables with application to a breast cancer study · SiM · 2016-05-29 · 在第 17 页
- Defining and estimating causal direct and indirect effects when setting the mediator to specific values is not feasible · SiM · 2016-05-26 · 在第 17 页
- Model selection versus model averaging in dose finding studies · SiM · 2016-05-25 · 在第 17 页
- Graphical approaches using a Bonferroni mixture of weighted Simes tests · SiM · 2016-05-25 · 在第 17 页
- Estimating the cumulative mean function for history process with time‐dependent covariates and censoring mechanism · SiM · 2016-05-24 · 在第 17 页
- Correlated probit analysis of repeatedly measured ordinal and continuous outcomes with application to the Health and Retirement Study · SiM · 2016-05-24 · 在第 17 页
- A Bayesian probit model with spatially varying coefficients for brain decoding using fMRI data · SiM · 2016-05-24 · 在第 18 页
- Utility‐based designs for randomized comparative trials with categorical outcomes · SiM · 2016-05-18 · 在第 18 页
- Study design for non‐recurring, time‐to‐event outcomes in the presence of error‐prone diagnostic tests or self‐reports · SiM · 2016-05-18 · 在第 18 页
- Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model · SiM · 2016-05-18 · 在第 18 页
- Probabilistic measures of cost‐effectiveness · SiM · 2016-05-18 · 在第 18 页
- Estimating the expected value of partial perfect information in health economic evaluations using integrated nested Laplace approximation · SiM · 2016-05-18 · 在第 18 页
- An adaptive dose‐finding method using a change‐point model for molecularly targeted agents in phase I trials · SiM · 2016-05-11 · 在第 18 页
- A new measure of between‐studies heterogeneity in meta‐analysis · SiM · 2016-05-10 · 在第 18 页
- A flexible, interpretable framework for assessing sensitivity to unmeasured confounding · SiM · 2016-05-03 · 在第 19 页
- A flexible parametric approach for estimating continuous‐time inverse probability of treatment and censoring weights · SiM · 2016-05-02 · 在第 19 页
- A three-step estimation procedure using local polynomial smoothing for inconsistently sampled longitudinal data · SiM · 2016-04-27 · 在第 20 页
- MIDAS: a practical Bayesian design for platform trials with molecularly targeted agents · SiM · 2016-04-25 · 在第 20 页
- Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis‐driven selection rules · SiM · 2016-04-21 · 在第 20 页
- Test equality in binary data for a 4 × 4 crossover trial under a Latin‐square design · SiM · 2016-04-21 · 在第 20 页
- Likelihood ratio and score tests to test the non-inferiority (or equivalence) of the odds ratio in a crossover study with binary outcomes · SiM · 2016-04-19 · 在第 20 页
- Testing of evaluation bias for progression free survival endpoint in oncology clinical trials · SiM · 2016-04-18 · 在第 20 页
- Targeted estimation and inference for the sample average treatment effect in trials with and without pair‐matching · SiM · 2016-04-18 · 在第 20 页
- Linear models of coregionalization for multivariate lattice data: a general framework for coregionalized multivariate CAR models · SiM · 2016-04-18 · 在第 20 页
- Joint modelling of longitudinal and multi‐state processes: application to clinical progressions in prostate cancer · SiM · 2016-04-18 · 在第 20 页
- Improving power in small‐sample longitudinal studies when using generalized estimating equations · SiM · 2016-04-18 · 在第 20 页
- Handling incomplete correlated continuous and binary outcomes in meta‐analysis of individual participant data · SiM · 2016-04-18 · 在第 20 页
- Estimating the prevalence of multiple diseases from two‐stage hierarchical pooling · SiM · 2016-04-18 · 在第 20 页
- Dimension of model parameter space and operating characteristics in adaptive dose‐finding studies · SiM · 2016-04-18 · 在第 20 页
- Ascertainment correction in frailty models for recurrent events data · SiM · 2016-04-18 · 在第 20 页
- Group sequential designs with prospectively planned rules for subpopulation enrichment · SiM · 2016-04-13 · 在第 20 页
- Calibrating random forests for probability estimation · SiM · 2016-04-13 · 在第 20 页
- Meta‐STEPP: subpopulation treatment effect pattern plot for individual patient data meta‐analysis · SiM · 2016-04-12 · 在第 20 页
- Estimation of adjusted rate differences using additive negative binomial regression · SiM · 2016-04-12 · 在第 20 页
- A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trials · SiM · 2016-04-07 · 在第 21 页
- Simple generalized estimating equations (GEEs) and weighted generalized estimating equations (WGEEs) in longitudinal studies with dropouts: guidelines and implementation in R · SiM · 2016-04-05 · 在第 21 页
- Combining biomarkers linearly and nonlinearly for classification using the area under the ROC curve · SiM · 2016-04-05 · 在第 21 页
- A rank test for bivariate time‐to‐event outcomes when one event is a surrogate · SiM · 2016-04-05 · 在第 21 页
- A conditional approach for modelling patient readmissions to hospital using a mixture of Coxian phase‐type distributions incorporating Bayes' theorem · SiM · 2016-04-05 · 在第 21 页
- Dealing with missing covariates in epidemiologic studies: a comparison between multiple imputation and a full Bayesian approach · SiM · 2016-04-04 · 在第 21 页
- Power/sample size calculations for assessing correlates of risk in clinical efficacy trials · SiM · 2016-03-31 · 在第 21 页
- Hierarchical Bayesian approaches for detecting inconsistency in network meta-analysis · SiM · 2016-03-31 · 在第 21 页
- Estimation of time-shift models with application to survival calibration in health technology assessment · SiM · 2016-03-31 · 在第 21 页
- Doubly robust survival trees · SiM · 2016-03-31 · 在第 21 页
- New insights into the evaluation of randomized controlled trials for rare diseases over a long‐term research horizon: a simulation study · SiM · 2016-03-30 · 在第 21 页
- Joint longitudinal hurdle and time-to-event models: an application related to viral load and duration of the first treatment regimen in patients with HIV initiating therapy · SiM · 2016-03-29 · 在第 22 页
- Adaptive dose modification for phase I clinical trials · SiM · 2016-03-29 · 在第 22 页
- Two-sample tests and one-way MANOVA for multivariate biomarker data with nondetects · SiM · 2016-03-21 · 在第 22 页
- Optimal flexible sample size design with robust power · SiM · 2016-03-21 · 在第 22 页
- On variance estimate for covariate adjustment by propensity score analysis · SiM · 2016-03-21 · 在第 22 页
- A multivariate cure model for left‐censored and right‐censored data with application to colorectal cancer screening patterns · SiM · 2016-03-18 · 在第 22 页
- Methods for testing the Markov condition in the illness-death model: a comparative study · SiM · 2016-03-16 · 在第 22 页
- A default method to specify skeletons for Bayesian model averaging continual reassessment method for phase I clinical trials · SiM · 2016-03-16 · 在第 23 页
- Delta method and bootstrap in linear mixed models to estimate a proportion when no event is observed: application to intralesional resection in bone tumor surgery · SiM · 2016-03-15 · 在第 23 页
- Multiple imputation methods for bivariate outcomes in cluster randomised trials · SiM · 2016-03-14 · 在第 23 页
- Bayesian joint modeling of longitudinal and spatial survival AIDS data · SiM · 2016-03-14 · 在第 23 页
- A marginal rank‐based inverse normal transformation approach to comparing multiple clinical trial endpoints · SiM · 2016-03-14 · 在第 23 页
- Limitations of empirical calibration of p‐values using observational data · SiM · 2016-03-10 · 在第 23 页
- Empirical extensions of the lasso penalty to reduce the false discovery rate in high‐dimensional Cox regression models · SiM · 2016-03-10 · 在第 23 页
- Repeated significance tests of linear combinations of sensitivity and specificity of a diagnostic biomarker · SiM · 2016-03-07 · 在第 23 页
- Graphical and numerical diagnostic tools to assess suitability of multiple imputations and imputation models · SiM · 2016-03-07 · 在第 23 页
- Bayesian Peer Calibration with Application to Alcohol Use · SiM · 2016-03-04 · 在第 23 页
- A multivariate method for meta-analysis and comparison of diagnostic tests · SiM · 2016-03-04 · 在第 23 页
- Rank‐preserving regression: a more robust rank regression model against outliers · SiM · 2016-03-02 · 在第 23 页
- Estimating restricted mean treatment effects with stacked survival models · SiM · 2016-03-02 · 在第 23 页
- The bivariate combined model for spatial data analysis · SiM · 2016-02-29 · 在第 23 页
- Implementation of adaptive methods in early‐phase clinical trials · SiM · 2016-02-29 · 在第 23 页
- Intra‐cluster correlation selection for cluster randomized trials · SiM · 2016-02-28 · 在第 23 页
- A multilevel excess hazard model to estimate net survival on hierarchical data allowing for non‐linear and non‐proportional effects of covariates · SiM · 2016-02-28 · 在第 23 页
- A Cochran–Armitage‐type and a score‐free global test for multivariate ordinal data · SiM · 2016-02-28 · 在第 23 页
- Fallback tests for co‐primary endpoints · SiM · 2016-02-25 · 在第 23 页
- Correcting treatment effect for treatment switching in randomized oncology trials with a modified iterative parametric estimation method · SiM · 2016-02-25 · 在第 23 页
- Assessing agreement with relative area under the coverage probability curve · SiM · 2016-02-25 · 在第 23 页
- Type‐II generalized family‐wise error rate formulas with application to sample size determination · SiM · 2016-02-23 · 在第 24 页
- Using the entire history in the analysis of nested case cohort samples · SiM · 2016-02-22 · 在第 24 页
- Nonparametric estimation of the rediscovery rate · SiM · 2016-02-22 · 在第 24 页
- Identifying a maximum tolerated contour in two‐dimensional dose finding · SiM · 2016-02-22 · 在第 24 页
- Modelling semi‐attributable toxicity in dual‐agent phase I trials with non‐concurrent drug administration · SiM · 2016-02-19 · 在第 24 页
- Adjusting for unmeasured confounding due to either of two crossed factors with a logistic regression model · SiM · 2016-02-19 · 在第 24 页
- Finite sample pointwise confidence intervals for a survival distribution with right‐censored data · SiM · 2016-02-18 · 在第 24 页
- Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies · SiM · 2016-02-18 · 在第 24 页
- A multiple imputation approach for MNAR mechanisms compatible with Heckman's model · SiM · 2016-02-18 · 在第 24 页
- Score test for association between recurrent events and a terminal event · SiM · 2016-02-17 · 在第 24 页
- Interval estimation of small tail probabilities – applications in food safety · SiM · 2016-02-17 · 在第 24 页
- An improved cumulative sum‐based procedure for prospective disease surveillance for count data in multiple regions · SiM · 2016-02-17 · 在第 24 页
- Recurrent event data analysis with intermittently observed time‐varying covariates · SiM · 2016-02-16 · 在第 24 页
- Meta‐analysis with missing study‐level sample variance data · SiM · 2016-02-16 · 在第 24 页
- Integrative genomic testing of cancer survival using semiparametric linear transformation models · SiM · 2016-02-16 · 在第 24 页
- Inference on treatment‐covariate interaction based on a nonparametric measure of treatment effects and censored survival data · SiM · 2016-02-16 · 在第 24 页
- Heteroscedastic transformation cure regression models · SiM · 2016-02-16 · 在第 24 页
- Analyzing clinical trial outcomes based on incomplete daily diary reports · SiM · 2016-02-16 · 在第 24 页
- A latent process model for forecasting multiple time series in environmental public health surveillance · SiM · 2016-02-16 · 在第 24 页
- Finding common task‐related regions in fMRI data from multiple subjects by periodogram clustering and clustering ensemble · SiM · 2016-02-15 · 在第 24 页
- Bayesian reclassification statistics for assessing improvements in diagnostic accuracy · SiM · 2016-02-14 · 在第 24 页
- Using family members to augment genetic case–control studies of a life‐threatening disease · SiM · 2016-02-11 · 在第 25 页
- Estimating effectiveness in HIV prevention trials with a Bayesian hierarchical compound Poisson frailty model · SiM · 2016-02-11 · 在第 25 页
- Bayesian linear regression with skew-symmetric error distributions with applications to survival analysis · SiM · 2016-02-09 · 在第 25 页
- Sequential monitoring of Phase I dose expansion cohorts · SiM · 2016-02-07 · 在第 25 页
- Nonparametric survival analysis using Bayesian Additive Regression Trees (BART) · SiM · 2016-02-07 · 在第 25 页
- Bayesian multinomial probit modeling of daily windows of susceptibility for maternal PM2.5 exposure and congenital heart defects · SiM · 2016-02-07 · 在第 25 页
- Variable selection for distribution‐free models for longitudinal zero‐inflated count responses · SiM · 2016-02-04 · 在第 25 页
- Hartung–Knapp method is not always conservative compared with fixed‐effect meta‐analysis · SiM · 2016-02-04 · 在第 25 页
- A practical divergence measure for survival distributions that can be estimated from Kaplan-Meier curves · SiM · 2016-02-04 · 在第 25 页
- The use of asymmetric distributions in average bioequivalence · SiM · 2016-02-02 · 在第 25 页
- Testing moderation in network meta‐analysis with individual participant data · SiM · 2016-02-02 · 在第 25 页
- Exact confidence intervals for the average causal effect on a binary outcome · SiM · 2016-02-02 · 在第 25 页
- Design and analysis of clinical trials in the presence of delayed treatment effect · SiM · 2016-02-02 · 在第 25 页
- Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials · SiM · 2016-02-02 · 在第 25 页
- Using blocked fractional factorial designs to construct discrete choice experiments for healthcare studies · SiM · 2016-01-28 · 在第 25 页
- The modeling of medical expenditure data from a longitudinal survey using the generalized method of moments (GMM) approach · SiM · 2016-01-28 · 在第 25 页
- How to regress and predict in a Bland-Altman plot? Review and contribution based on tolerance intervals and correlated-errors-in-variables models · SiM · 2016-01-28 · 在第 26 页
- Correlation structure and variable selection in generalized estimating equations via composite likelihood information criteria · SiM · 2016-01-28 · 在第 26 页
- Double robust estimator of average causal treatment effect for censored medical cost data · SiM · 2016-01-27 · 在第 26 页
- Age-space-time CAR models in Bayesian disease mapping · SiM · 2016-01-26 · 在第 26 页
- Spatiotemporal calibration and resolution refinement of output from deterministic models · SiM · 2016-01-21 · 在第 26 页
- Easy and accurate variance estimation of the nonparametric estimator of the partial area under the ROC curve and its application · SiM · 2016-01-21 · 在第 26 页
- Bayesian methods of confidence interval construction for the population attributable risk from cross‐sectional studies · SiM · 2016-01-21 · 在第 26 页
- Validity and power considerations on hypothesis testing under minimization · SiM · 2016-01-19 · 在第 26 页
- Real‐time surveillance for abnormal events: the case of influenza outbreaks · SiM · 2016-01-18 · 在第 26 页
- Improving and extending the McNemar test using the Bayesian method · SiM · 2016-01-18 · 在第 26 页
- A hidden Markov model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified · SiM · 2016-01-18 · 在第 26 页
- On ‘Efficient statistical tests to compare Youden index: accounting for contingency correlation’ · SiM · 2016-01-17 · 在第 26 页
- The missing cause approach to unmeasured confounding in pharmacoepidemiology · SiM · 2016-01-14 · 在第 26 页
- Evaluating predictors of competing risk outcomes when censoring depends on time‐dependent covariates, with application to safety and efficacy of HIV treatment · SiM · 2016-01-14 · 在第 26 页
- Repairing the efficiency loss due to varying cluster sizes in two‐level two‐armed randomized trials with heterogeneous clustering · SiM · 2016-01-12 · 在第 26 页
- Integrative and regularized principal component analysis of multiple sources of data · SiM · 2016-01-12 · 在第 26 页
- An objective re‐evaluation of adaptive sample size re‐estimation: commentary on ‘Twenty‐five years of confirmatory adaptive designs’ · SiM · 2016-01-12 · 在第 26 页
- Evidence, eminence and extrapolation · SiM · 2016-01-11 · 在第 26 页
- Q‐learning residual analysis: application to the effectiveness of sequences of antipsychotic medications for patients with schizophrenia · SiM · 2016-01-10 · 在第 27 页
- Quantifying risk over the life course – latency, age‐related susceptibility, and other time‐varying exposure metrics · SiM · 2016-01-10 · 在第 27 页
- Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty model · SiM · 2016-01-10 · 在第 27 页
- Statistical efficiency and optimal design for stepped cluster studies under linear mixed effects models · SiM · 2016-01-07 · 在第 27 页
- A two‐stage approach for dynamic prediction of time‐to‐event distributions · SiM · 2016-01-07 · 在第 27 页
- Simpson's paradox in the integrated discrimination improvement · SiM · 2016-01-05 · 在第 27 页
- Meta-analysis of ratios of sample variances · SiM · 2016-01-05 · 在第 27 页
- Low‐event‐rate meta‐analyses of clinical trials: implementing good practices · SiM · 2016-01-05 · 在第 27 页
- Calibration and seasonal adjustment for matched case–control studies of vitamin D and cancer · SiM · 2016-01-05 · 在第 27 页
- A comparison of change point models with application to longitudinal lung function measurements in children with cystic fibrosis · SiM · 2016-01-05 · 在第 27 页
- The use of repeated blood pressure measures for cardiovascular risk prediction: a comparison of statistical models in the ARIC study · SiM · 2016 · 在第 27 页
- Random effects meta‐analysis: Coverage performance of 95 % confidence and prediction intervals following REML estimation · SiM · 2016 · 在第 28 页
- Prior event rate ratio adjustment for hidden confounding in observational studies of treatment effectiveness: a pairwise Cox likelihood approach · SiM · 2016 · 在第 29 页
- Developing points‐based risk‐scoring systems in the presence of competing risks · SiM · 2016 · 在第 32 页